Reversible male contraceptive shows promise in pre-clinical studies
Researchers have discovered the the compound triptonide is safe, effective and reversible as a male contraceptive in animal models.
List view / Grid view
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
Researchers have discovered the the compound triptonide is safe, effective and reversible as a male contraceptive in animal models.
Using high-throughput screening techniques, researchers have identified two families of active substances that block SARS-CoV-2 replication.
26 February 2021 | By Domain Therapeutics
Watch our on-demand webinar which focused on the progress achieved in G protein-coupled receptor (GPCR) therapeutic antibody-based discovery and development.
A new compound can inhibit the build-up of plaque in arteries and prevent atherosclerosis, researchers have shown.
According to a new report, the high-throughput screening market will increase at a CAGR of 11.5 percent from 2020 to 2025.
Researchers have developed a workflow to study the behaviour of C. elegans in a high-throughput screen to identify Parkinson's disease drugs.
Between January and October 2020, scientists globally have published more than 87,000 papers about the coronavirus.
Scientists have developed a compound that stops the degeneration of upper motor neurons, a contributor to amyotrophic lateral sclerosis (ALS).
Discover the latest in SARS-CoV-2 antibody research as we cover three of the most recent developments in this article.
A team has shown that STING activation is a new molecular target in the fight against graft-versus-host disease (GVHD).
In a zebrafish model, researchers have found that the protein NAPMT can trigger muscle stem cells to proliferate and heal muscle damage.
This whitepaper describes the automated culturing of hiPSC-derived cells for high-throughput phenotypic screening, using validated phenotypic assays.
New research has shown that 'hidden' lysis genes in bacteriophages could be used in the development of a new class of antibiotics.
Jim Shanahan from SynDevRx explains why metabo-oncology treatment modalities could be the answer to a rise in metabolic disorders and cancers.
Researchers have discovered that thapsigargin has novel antiviral properties and is effective against COVID-19 in pre-clinical studies.